|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Sales | |||||
| Other revenue | |||||
| Total net sales | |||||
| Cost of sales | |||||
| Selling, General and Administrative Expense | |||||
| Depreciation and amortization (exclusive of depreciation included in cost of sales) | |||||
| Operating income | |||||
| Net interest expense | |||||
| Net other income | |||||
| Earnings before income taxes | |||||
| Provision for income taxes | |||||
| Net earnings | |||||
| Basic earnings per share (in usd per share) | |||||
| Diluted earnings per share (in usd per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Antidilutive shares (in shares) | |||||
Loading...